Bristol Myers Squibb Co (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. The Company's products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession.

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. Bristol Myers Squibb Co (NYSE:BMY) achieved its new 52 week high price of $34.68 where it was opened at $34.30 up 0.05 points or +0.15% by closing at $34.27.

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical products on a global basis. Bristol Myers Squibb Co (NYSE:BMY) achieved its new 52 week high price of $33.72 where it was opened at $33.08 UP 0.41 points or +1.24% by closing at $33.53.